Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Vireo Growth Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.66 |
52 Week High | CA$0.95 |
52 Week Low | CA$0.14 |
Beta | 1.42 |
11 Month Change | 6.45% |
3 Month Change | 11.86% |
1 Year Change | 247.37% |
33 Year Change | -67.16% |
5 Year Change | -76.00% |
Change since IPO | -86.80% |
Recent News & Updates
Recent updates
Market Might Still Lack Some Conviction On Goodness Growth Holdings, Inc. (CSE:GDNS) Even After 30% Share Price Boost
Jun 01Goodness Growth Holdings, Inc. (CSE:GDNS) Stock Rockets 30% But Many Are Still Ignoring The Company
Apr 06Investors Still Aren't Entirely Convinced By Goodness Growth Holdings, Inc.'s (CSE:GDNS) Revenues Despite 59% Price Jump
Feb 01Goodness Growth Holdings (CSE:GDNS) Is Carrying A Fair Bit Of Debt
Dec 14Health Check: How Prudently Does Goodness Growth Holdings (CSE:GDNS) Use Debt?
Jul 14Is Vireo Health International (CSE:VREO) Weighed On By Its Debt Load?
Mar 19Did Business Growth Power Vireo Health International's (CSE:VREO) Share Price Gain of 127%?
Jan 25Vireo Health International's (CSE:VREO) Shareholders Are Down 55% On Their Shares
Sep 04Shareholder Returns
VREO | CA Pharmaceuticals | CA Market | |
---|---|---|---|
7D | 10.0% | 0.8% | 0.8% |
1Y | 247.4% | 38.0% | 11.2% |
Return vs Industry: VREO exceeded the Canadian Pharmaceuticals industry which returned 41% over the past year.
Return vs Market: VREO exceeded the Canadian Market which returned 10.9% over the past year.
Price Volatility
VREO volatility | |
---|---|
VREO Average Weekly Movement | 17.5% |
Pharmaceuticals Industry Average Movement | 12.2% |
Market Average Movement | 8.0% |
10% most volatile stocks in CA Market | 16.7% |
10% least volatile stocks in CA Market | 3.0% |
Stable Share Price: VREO's share price has been volatile over the past 3 months.
Volatility Over Time: VREO's weekly volatility (18%) has been stable over the past year, but is still higher than 75% of Canadian stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
n/a | 438 | Josh Rosen | vireohealth.com |
Vireo Growth Inc. operates as a cannabis company in the United States. The company cultivates, manufactures, processes, and distributes medical and adult-use cannabis products. It sells cannabis products through its network of Green Goods and other Goodness Growth branded retail dispensaries and third-party dispensaries in Maryland, Minnesota, and New York.
Vireo Growth Inc. Fundamentals Summary
VREO fundamental statistics | |
---|---|
Market cap | CA$92.41m |
Earnings (TTM) | -CA$32.99m |
Revenue (TTM) | CA$128.81m |
0.8x
P/S Ratio-2.9x
P/E RatioIs VREO overvalued?
See Fair Value and valuation analysisEarnings & Revenue
VREO income statement (TTM) | |
---|---|
Revenue | US$93.13m |
Cost of Revenue | US$46.30m |
Gross Profit | US$46.83m |
Other Expenses | US$70.68m |
Earnings | -US$23.85m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 06, 2024
Earnings per share (EPS) | -0.16 |
Gross Margin | 50.28% |
Net Profit Margin | -25.61% |
Debt/Equity Ratio | -311.4% |
How did VREO perform over the long term?
See historical performance and comparison